Back

Progression of cardiac dysfunction in patients with hereditary transthyretin-related amyloidosis associated with glu89gln mutation

6 December 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 4 - Cardiomyopathies Restrictive cardiomyopathies EACVI Premium Access EuroEcho-Imaging 2017

About the speaker

Photo
Associate Professor Mariana Gospodinova-Milanova

UMHAT 'Ivan Rilski', Sofia (Bulgaria)

8 More presentations in this session

Presentation thumbnail
Prognostic value of collagen biomarkers on left atrial remodeling and arrhythmia on hypertrophic cardiomyopathy
Doctor A. Zaroui (Tunis, TN)
Presentation thumbnail
Increased age, biventricular involvement and advanced atrial disfunction are independently related to symptomatic status in patients with hypertrophic cardiomyopathy
Doctor M. Rosca (Bucharest, RO)
Abstract
Presentation thumbnail
3D left atrium ejection fraction predicts atrial fibrillation in hypertrophic cardiomyopathy
Doctor G. Pestana (Porto, PT)
Presentation thumbnail
Cardiac involvement, morbidity and mortality in hereditary transthyretin-related amyloidosis associated with glu89gln mutation
Associate Professor M. Gospodinova-Milanova (Sofia, BG)
Abstract
Presentation thumbnail
Echocardiographic features of early cardiac amyloidosis
Doctor B. Pawarova (London, GB)
Abstract

Access the full session

Session thumbnail
Poster session 4 - Cardiomyopathies

The Event

Event poster

EuroEcho-Imaging 2017

6 December - 9 December 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources